Gene · 6672
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The PML hub: An emerging actor of leukemia therapies. | J Exp Med | 2023 | 37382966 | PubTator, text mining | PubMed |
| Cured HCV patients with suboptimal hepatitis B vaccine response exhibit high self-reactive immune signatures. | Hepatol Commun | 2023 | 37378628 | PubTator, text mining | PubMed |
| A Novel Fusion Partner, SP100, Drives Nuclear Dot Localization of ALK in Epithelioid Fibrous Histiocytoma. | Am J Dermatopathol | 2023 | 37377191 | PubTator, text mining | PubMed |
| Conditional Cell Reprogramming and Air-Liquid Interface Modeling Life Cycle of Oncogenic Viruses (HPV and EBV) in Epithelial Cells and Virus-Associated Human Carcinomas. | Viruses | 2023 | 37376685 | PubTator, text mining | PubMed |
| Laboratory risk factors for coexistent primary biliary cholangitis in patients with Sjögren's syndrome: a retrospective study. | BMC Gastroenterol | 2023 | 37365494 | PubTator, text mining | PubMed |
| Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma. | Aging (Albany NY) | 2023 | 37354211 | PubTator, text mining | PubMed |
| SLF2 Interacts with the SMC5/6 Complex to Direct Hepatitis B Virus Episomal DNA to Promyelocytic Leukemia Bodies for Transcriptional Repression. | J Virol | 2023 | 37338350 | PubTator, text mining | PubMed |
| Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis. | Front Immunol | 2023 | 37325639 | PubTator, text mining | PubMed |
| Detection of M2-Type Anti-Mitochondrial Autoantibodies against Specific Subunits in the Diagnosis of Primary Biliary Cholangitis in Patients with Discordant Results. | Diagnostics (Basel) | 2023 | 37296692 | PubTator, text mining | PubMed |
| Serological markers of rheumatoid arthritis in patients with primary biliary cholangitis and the vice versa: A Tunisian study. | Immunobiology | 2023 | 37269587 | PubTator, text mining | PubMed |
| Primary biliary cholangitis: Epidemiology, prognosis, and treatment. | Hepatol Commun | 2023 | 37267215 | PubTator, text mining | PubMed |
| Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps. | Nat Methods | 2023 | 37248388 | PubTator, text mining | PubMed |
| PhosY-secretome profiling combined with kinase-substrate interaction screening defines active c-Src-driven extracellular signaling. | Cell Rep | 2023 | 37243593 | PubTator, text mining | PubMed |
| A Novel Recognition by the E3 Ubiquitin Ligase of HSV-1 ICP0 Enhances the Degradation of PML Isoform I to Prevent ND10 Reformation in Late Infection. | Viruses | 2023 | 37243155 | PubTator, text mining | PubMed |
| Interplay between PML NBs and HIRA for H3.3 dynamics following type I interferon stimulus. | Elife | 2023 | 37227756 | PubTator, text mining | PubMed |
| Gut microbial profile of treatment-naive patients with primary biliary cholangitis. | Front Immunol | 2023 | 37223092 | PubTator, text mining | PubMed |
| Clinicopathological features of 11 cases of chronic hepatitis B infection complicated with primary biliary cholangitis. | World J Hepatol | 2023 | 37206657 | PubTator, text mining | PubMed |
| SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA. | Microbiol Spectr | 2023 | 37199632 | PubTator, text mining | PubMed |
| Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies. | Cell Prolif | 2023 | 37199039 | PubTator, text mining | PubMed |
| Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines. | Sci Rep | 2023 | 37185361 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6672/papers?page=8